443 related articles for article (PubMed ID: 8759175)
1. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.
Fernandez-Soto L; Gonzalez A; Escobar-Jimenez F; Vazquez R; Ocete E; Olea N; Salmeron J
Arch Intern Med; 1998 Jul; 158(13):1445-8. PubMed ID: 9665354
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis C virus infection and thyroid diseases].
Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.
Preziati D; La Rosa L; Covini G; Marcelli R; Rescalli S; Persani L; Del Ninno E; Meroni PL; Colombo M; Beck-Peccoz P
Eur J Endocrinol; 1995 May; 132(5):587-93. PubMed ID: 7749499
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection.
Boadas J; Rodríguez-Espinosa J; Enríquez J; Miralles F; Martínez-Cerezo FJ; González P; Madoz P; Vilardell F
J Hepatol; 1995 Jun; 22(6):611-5. PubMed ID: 7560854
[TBL] [Abstract][Full Text] [Related]
6. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
7. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
[TBL] [Abstract][Full Text] [Related]
8. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
[TBL] [Abstract][Full Text] [Related]
9. [Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C].
Heller J; Musiolik J; Homrighausen A; Sauerbruch T; Spengler U
Dtsch Med Wochenschr; 1996 Sep; 121(39):1179-83. PubMed ID: 8925742
[TBL] [Abstract][Full Text] [Related]
10. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.
Indolfi G; Stagi S; Bartolini E; Salti R; de Martino M; Azzari C; Resti M
Clin Endocrinol (Oxf); 2008 Jan; 68(1):117-21. PubMed ID: 17692107
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
12. Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders.
Chen FQ; Okamura K; Sato K; Kuroda T; Mizokami T; Fujikawa M; Tsuji H; Okamura S; Fujishima M
Clin Endocrinol (Oxf); 1996 Aug; 45(2):207-14. PubMed ID: 8881454
[TBL] [Abstract][Full Text] [Related]
13. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
[TBL] [Abstract][Full Text] [Related]
14. Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C.
Kiehne K; Kloehn S; Hinrichsen H; Gallwitz B; Mönig H
Endocrine; 1997 Jun; 6(3):231-4. PubMed ID: 9368677
[TBL] [Abstract][Full Text] [Related]
15. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
Chung YH; Shong YK
Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
[TBL] [Abstract][Full Text] [Related]
16. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
[TBL] [Abstract][Full Text] [Related]
18. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
[TBL] [Abstract][Full Text] [Related]
19. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study.
Huang MJ; Tsai SL; Huang BY; Sheen IS; Yeh CT; Liaw YF
Clin Endocrinol (Oxf); 1999 Apr; 50(4):503-9. PubMed ID: 10468911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
